We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Contract Manufacturer in Warning Letter
FDA Cites Contract Manufacturer in Warning Letter
June 2, 2009
The quality control unit for Mississippi-based Pharma Pac has insufficient control over its production operations and did not establish adequate in-process controls for manufacturing the motion sickness drug meclizine HCl, according to an FDA warning letter.